Ultra Shear Technology: Revolutionary Process for Making the Highest Quality CBD Nanoemulsions Now Hitting the Market

October 10th, 2022 - Robin Lefferts

Cannabidiol, or CBD, and other cannabinoids are oil-based compounds. The human body is a water-based environment. To get the CBD where it needs to go, an emulsion of oil- and water-based ingredients has to be made. Emulsions can be achieved chemically or physically, and each approach has its downside. Most physical emulsions tend to separate […]

Why Coca Could Become the Next Superfood (and How to Invest)

June 28th, 2022 - Ryan Allway

  Superfoods refer to nutrient-rich foods that convey positive health benefits. While catechin-rich green tea, fisetin-rich strawberries, and omega-3-rich walnuts are well-known superfoods, coca leaves remain relatively undiscovered due to their association with cocaine. But fortunately, decocainized coca leaves open the door to new possibilities. Let’s take a deep dive into the nutritional benefits of […]

Why You Should Invest in Europe’s Cannabis Industry (and Its Upcoming Leader)

April 25th, 2022 - Ryan Allway

  The North American cannabis industry has struggled over the past couple of years, but fundamentals are improving and valuations are becoming attractive. As North America continues to grapple with excess supply issues, challenging margins and regulations, investors are starting to turn their attention toward European markets that are in the early innings of adoption […]

Premium Veganic Mendocino Cannabis: Interview with Ethan Styles

April 11th, 2022 - Robin Lefferts

Pharmagreen Biotech Inc. (OTCQB: PHBI) is in the process of acquiring Long Valley Farms LLC as part of its strategy to create a vertically integrated premium cannabis operation in California. Long Valley Farms is located in Mendocino County in the heart of California’s famed Emerald Triangle. We had a chance to speak with Ethan Styles, […]

CFN Media Sits Down with Hero’s Blackbox CEO Marc Kasabasic to Discuss the Company’s Unique Technology

April 1st, 2022 - Robin Lefferts

Hero Technologies Inc. (OTC: HENC) is focused on building a vertically integrated cannabis operation in Michigan that will expand to become a multi-state operation. The company is currently in the midst of the licensing process in Michigan. In anticipation of receiving the appropriate licenses, Hero has been laying the groundwork for construction of a large […]

A Vertical Cannabis Company in the Making

March 22nd, 2022 - Robin Lefferts

In the cannabis industry there are several business models that may make sense, depending on a company’s capabilities, people, and markets. There are wholesalers, distributors, retailers, propagators, brand houses, laboratories, multi-state operators … the list goes on. If a company puts all the right pieces together, a vertically integrated model could make sense to keep […]

New Player in the Michigan Cannabis Market

March 14th, 2022 - Robin Lefferts

The state of Michigan is one of the hottest legal cannabis markets in the United States. According to Andrew Brisbo, Executive Director of Michigan’s Marijuana Regulatory Agency, the state recently passed the $3 billion dollar mark in total sales since October 2018. For 2021 alone, total sales topped $1.79 billion. The industry has been growing […]

Psychedelic Treatment for Depression Moving Toward Clinical Trials

January 25th, 2022 - Robin Lefferts

Depression, or more formally Major Depressive Disorder (MDD), is a widespread and growing problem across the globe. In the United States in 2019, 19.4 million adults (7.8% of all adults) were estimated to have a major depressive episode. About two-thirds of these people received treatment of some sort, and the most effective treatments produce roughly 30 to 40 […]

NutraLife Accelerates Expansion into the Rapidly Growing $11 Billion CBD Industry

January 10th, 2022 - Ryan Allway

CBD has become one of the fastest-growing wellness products globally, reaching more than $11 billion in global sales last year. According to Market Data Forecast, these sales will continue to grow at a 22.2% annual pace to nearly $31 billion by 2026. As a result, companies building an early presence in the industry could be […]

3 Ways to Invest in Ketamine Clinics

January 6th, 2022 - Ryan Allway

Researchers believe that psychedelics may revolutionize mental health treatments, but FDA-approved psychedelics remain out of reach—with one exception. Unlike psilocybin or MDMA, ketamine is FDA-approved for anesthesia during medical procedures, opening the door to off-label use as a treatment for depression and other mental illnesses. With the FDA’s approval of Spravato and a growing body […]

How to Capitalize on Europe’s Exploding CBD Market

December 28th, 2021 - Ryan Allway

  Europe is the second-largest CBD market in the world after North America, with over 500 million potential customers. According to Brightfield Group, the European CBD market will grow from €270 million in 2018 to €1.4 billion by 2023, representing a blistering 42% compound annual growth rate, making it one of the fastest-growing markets. While […]

CBD Life Sciences Doubles Down on Self-Service with CBD Vending Machine & Bitcoin ATMs

December 15th, 2021 - Ryan Allway

CBD Life Sciences Inc. (OTC Pink: CBDL) operates a brick-and-mortar CBD store in Scottsdale, Arizona, and an online shop at LBLBioscienceInc.com. While many companies are content with these distribution channels, the company continues to innovate with new self-service machines targeting both CBD and crypto sectors. Let’s look at how these moves could pay off over […]

PODA Offers a New Take on Heat-Not-Burn Products

December 8th, 2021 - Ryan Allway

Countries worldwide are adopting tobacco harm reduction policies to reduce smoking-related deaths and diseases. While smoking prevention and cessation are the centerpieces of these strategies, scientists believe that public health outcomes among smokers could significantly improve if they switch to non-combustible alternatives. Heat-not-burn products, such as Philip Morris’ IQOS, may reduce exposure to harmful chemicals […]

Craft Cannabis is the Future & Micro-Cultivators Will Lead the Way

December 3rd, 2021 - Ryan Allway

  Canada’s legal cannabis industry is flooded with products that prioritize profits over quality. While many consumers are price-sensitive, Deloitte Canada found that 86% of Millennial and Gen Z consumers are willing to buy premium products. These trends mirror many other industries where premium products are beating out generic competitors. Maven Brands Inc. (CSE: MJ) […]

How to Capitalize on Germany’s Move to Legalize Cannabis

November 30th, 2021 - Ryan Allway

Germany’s incoming governing parties recently announced a formal agreement to legalize adult-use cannabis when they take power. While personal possession has already been decriminalized, the new proposal seeks to establish a regulated market for adult-use cannabis. The move could create an industry like those in Canada and some U.S. states. While the legislation won’t be […]

While Psychedelics Wait, Ketamine Revenues Roll On

November 30th, 2021 - Ryan Allway

The nature of the psychedelic market today means that public company investors are making largely speculative investments. Though there are plenty of studies demonstrating the efficacy of substances ranging from LSD to psilocybin to MDMA, the fact remains they are Schedule 1 controlled substances and have not been approved for therapeutic use. Companies seeking such […]

Vape Industry Uncertainty Could Benefit PODA Alternative

November 16th, 2021 - Robin Lefferts

Vape issues, from teens taking up the habit in large numbers to health concerns, were dominating headlines a couple years back. In response to the industry’s sudden boom and the potential problems associated with vape use, the US Food and Drug Administration (FDA) created a set of standards and a new process for approving vape […]

Maven Brands Unleashes the Potential of Craft Micro-Cultivators in Canada

November 10th, 2021 - Ryan Allway

Micro-cultivators have become one of the fastest-growing segments of the cannabis industry. Consumers strongly prefer craft cannabis after the explosion of low-quality and over-priced products hit the retail market following legalization. Unfortunately, many restrictions and obstacles keep micro-cultivators from reaching the market. Newly re-branded Maven Brands Inc. (CSE: MJ) (OTC Pink: TRLFF) (FSE: TLAA) is […]

Teen THC Vaping on the Rise: Solutions Beyond Government Regulations

November 9th, 2021 - Ryan Allway

Teen vaping of marijuana doubled between 2013 and 2020, according to a new study. In addition to harmful side effects, these trends are compounding problems that governments and businesses are already struggling with among the legal cannabis-consuming population. Fortunately, new technologies could be on the way to help detect and deter illegal use. Let’s look […]

Flora Growth Looks to Bridge the Gap Between Cannabis & Pharmaceuticals

October 15th, 2021 - Ryan Allway

  Cannabis-based pharmaceutical drug products remain a niche market despite the plant’s significant promise. By acting on the endocannabinoid system, a widespread neuromodulator that plays an important role in everything from central nervous system development to synaptic plasticity, cannabinoids have the potential to treat a wide range of conditions. Dronabinol, a synthetic version of THC, […]

Building the DoorDash or UberEats of Psychedelics

October 14th, 2021 - Ryan Allway

The psychedelics industry is rapidly growing, with more than 50 publicly traded companies worth billions of dollars. At the same time, the FDA’s approval of Spravato (esketamine) for treatment-resistant depression and the growing body of clinical evidence could provide further tailwinds for the industry over the coming decade and beyond. Unfortunately, many patients live in […]

BioHarvest Looks to Make Cannabis More Sustainable

October 13th, 2021 - Ryan Allway

Investors have become increasingly environmentally conscious over the past few years, evidenced by the tremendous growth in ESG funds. But, unfortunately, investors in the cannabis industry may be surprised by its significant environmental impact. Fortunately, many companies are working to improve the situation and make the industry more “green.” Let’s take a closer look at […]

Heat-Not-Burn Could Replace Vapes to Help Adult Smokers Reduce Risk without Attracting Youth, Non-Smokers

October 12th, 2021 - Ryan Allway

Most adults and regulators recognize the harm of tobacco, but flavored high-nicotine vaping products have evaded regulatory scrutiny. While the U.K., Europe, and Canada outlawed vape products containing high nicotine levels, the FDA only recently denied marketing approval for hundreds of vape brands and ordered them off store shelves. The new FDA ban prevents many […]

Poda’s eCig Alternative Could Catch Fire in the U.S.

September 28th, 2021 - Ryan Allway

  Most U.S. smokers are familiar with e-cigarettes, like Juul, that offer a nicotine experience. But, unfortunately, their catchy flavors have attracted nonsmokers—including young people—and that has caught the attention of the Food and Drug Administration (FDA). Recent crackdowns threaten to kill the nascent vaping industry, leaving a massive vacuum. Poda Holdings, Inc. (CSE: PODA) […]

Ketamine Offers Promise to Veterans with PTSD

September 24th, 2021 - Ryan Allway

  Post-traumatic stress disorder, or PTSD, is a common mental illness among veterans. According to the Department of Veteran Affairs, 11% to 30% of veterans who served in foreign wars experience PTSD, far higher than the estimated 6% of the general population. PTSD manifests in many ways, ranging from depression to chronic fatigue. The FDA’s […]

BioHarvest Provides Unmatched Consistency & Variety in Cannabis

September 14th, 2021 - Ryan Allway

  The cannabis industry is quickly evolving from dried cannabis to beverages and other product formats. At the same time, the pharmaceutical industry is increasingly embracing cannabinoids for their potential therapeutic benefits. The challenge is converting raw plant material into a consistent format with the right mix of cannabinoids. Let’s look at the importance of […]

Cannabix Addresses Challenges with Marijuana Testing in the Workplace

September 13th, 2021 - Ryan Allway

Marijuana legalization is on the rise across the United States. While decriminalization is a noble cause, there are many unintended consequences that the government and private sector struggle to manage. One of the most significant challenges is detecting when someone is under the influence of marijuana. Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is an […]

Silo Pharma Expanding Drug Delivery IP Portfolio

September 7th, 2021 - Robin Lefferts

While inflammation in general contributes to a wide range of diseases, swelling of the central nervous system (CNS) is associated with conditions including Parkinson’s disease, multiple sclerosis, chronic back pain, bipolar disorder, cancer cachexia, Alzheimer’s disease, and many more. Treatment of inflammation in the CNS is difficult due to the role of the blood-brain barrier […]

Psychedelic Experience: Treating the Trip that Never Ends

August 30th, 2021 - Robin Lefferts

  Psychedelics, including ketamine, psilocybin, and LSD, are gaining traction in the mental health industry as they have been found to be potentially beneficial for conditions ranging from depression to anxiety to PTSD to alcoholism. As psychedelics are entering the mainstream of science and health, more is being discovered about a condition called Hallucinogen Persisting […]

Big Data and AI Can Guide Cannabis Medicine

August 30th, 2021 - Robin Lefferts

In order for cannabis medicine to make the big leap to mainstream acceptance, a few things likely have to take place. Doctors, not just cannabis providers, need to become more comfortable discussing and prescribing the plant. Regulations need to become more homogenous and universal, like the pharmaceutical industry. Pharma companies need to advance more cannabis-derived […]

Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer